Molecular Bioelectrostatics & Drug Delivery Laboratory
Located at Northeastern University’s Interdisciplinary Science and Engineering Complex (ISEC), the Bajpayee Lab works at the intersection of biomaterials design, nanomedicine and translational research. We utilize the body’s internal electric fields to design electrically charged biomaterials using proteins, peptides and cellular materials like exosomes, for targeting difficult to reach tissues for applications in drug delivery and diagnostic imaging.
Negatively charged tissues such as cartilage, meniscus, intervertebral disc, eye, and mucosal membrane, that also tend to be dense and avascular, are ubiquitous in the human body but remain outstanding challenges for targeted drug delivery. Their degeneration is associated with several common diseases that remain untreatable due to a lack of delivery systems that can enable drugs to penetrate the negatively charged matrix and reach their cellular targets. The high negative fixed charge density, however, can be converted from being a challenge to an opportunity by engineering therapeutics at the molecular level to add optimally positively charged domains such that electrostatic interactions can enhance their transport, uptake and retention rather than hindering them. Our lab engineers targeted bioelectrical therapeutics for treatment of diseases affecting such intrinsically charged tissues. We strive to combine basic science with translational research to develop biomedical technologies for unmet clinical needs.
Follow us on Twitter @bajpayeelab | @AmbikaBajpayee

We are supported by

Our Lab News
Congratulations to Dr. Tim Boyer and co-authors on the recent publish work on cartilage targeting IL-1RA to prevent OA inflammation in Osteoarthritis and Cartilage
In this work, led by Dr. Tim Boyer, we engineered a cationic interleukin-1 receptor antagonist (cat-IL-1Ra) by fusing a cartilage-targeting cationic peptide carrier (CPC) to IL-1Ra. This design enabled selective targeting of anionic cartilage and the formation of...
Congratulations to Helna Baby and co-authors on the publication of their book chapter in Harnessing Endogenous Mechanisms for Targeted Drug Delivery!
Our new book chapter, led by Helna, explores the role of extracellular vesicles (EVs) in biological membrane trafficking and discusses their inherent limitations. The chapter further presents engineering design principles and state-of-the-art surface modification...
Our Cartilage-Targeting CPC Platform for Diagnostic Applications Has Been Patented!
Our work, pioneered by Dr. Chenzhen Zhang (read the paper [HERE]), showcased CPC's capability to enhance contrast agent delivery for CT imaging purposes. The patented platform provided a high-quality imaging modality at a significantly lower dosage compared to the...






